Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRicardo Plc Regulatory News (RCDO)

  • This share is currently suspended. It was suspended at a price of 430.00
  • There is currently no data for RCDO

Director/PDMR Shareholding

16 Oct 2013 16:25

RNS Number : 6917Q
Ricardo PLC
16 October 2013
 



Ricardo PLC

 

Director / PDMR Shareholdings

 

16 October 2013

London

 

1. 2006 Long Term Incentive Plan - grant of plan cycle 7

 

Ricardo PLC (the "Company") announces that, on 16 October 2013, conditional awards over a total of 185,399 shares of 25 pence each in the Company ("Shares") were granted to Executive Directors and other PDMRs under the terms of the Company's 2006 Long Term Incentive Plan (the "LTIP"), as set out below. These awards vest after three years and are subject to TSR and EPS performance conditions.

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

73,380

Ian Gibson

Executive Director

25,983

Mark Garrett

Executive Director

22,676

Martin Fausset

PDMR

14,430

Tom Apostolos

PDMR

9,423

Robert Hentschel

PDMR

8,615

Markus Döerr

PDMR

12,674

Gary Tan

PDMR

9,199

Robert Bell

PDMR

9,019

 

2. 2011 Deferred Bonus Plan - grant of deferred awards and matching awards

 

The Company also announces that, on 16 October 2013, conditional "deferred awards" over a total of 62,931 Shares were granted to Executive Directors and other PDMRs under the terms of the Company's 2011 Deferred Bonus Plan ("DBP"), as set out below. Subject to continuing employment, these awards vest after three years. These DBP deferred awards (which include dividend equivalent entitlements) are not subject to performance conditions.

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

34,292

Mark Garrett

Executive Director

15,620

Martin Fausset

PDMR

5,848

Tom Apostolos

PDMR

3,817

Gary Tan

PDMR

3,354

 

Finally, further conditional "matching awards" over a total of 49,912 Shares were granted to Executive Directors under the terms of the DBP on the basis of one Share comprised in such a "matching award" for each Share comprised in the corresponding deferred award (detailed above) granted to an individual on the same occasion. Details of these DBP matching awards, which do not include dividend equivalent entitlements, but are subject to the same performance conditions that apply to the awards granted on 16 October 2013 under cycle 7 of the LTIP, are set out below:

 

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

34,292

Mark Garrett

Executive Director

15,620

 

 

3. Current total holdings of awards / options over Shares

 

Following the above notifications, the total number of Shares over which the relevant Executive Directors and other PDMRs hold outstanding awards / options is set out below:

 

 Name

Role

Total no. of Shares subject to awards and options now held

Approximate % of Company's issued share capital

Dave Shemmans

Executive Director

616,044

1.18%

Ian Gibson

Executive Director

25,983

0.05%

Mark Garrett

Executive Director

221,144

0.42%

Martin Fausset

PDMR

71,753

0.14%

Tom Apostolos

PDMR

36,699

0.07%

Robert Hentschel

PDMR

8,615

0.02%

Markus Döerr

PDMR

99,208

0.19%

Gary Tan

PDMR

29,972

0.06%

Robert Bell

PDMR

23,554

0.05%

 

The above notifications are intended to satisfy the Company's obligations under Disclosure and Transparency Rule ("DTR") 3.1.4R.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZMMMGKVDGFZM
Date   Source Headline
2nd Jan 20254:37 pmRNSHolding(s) in Company
2nd Jan 20257:00 amRNSRicardo completes sale of Ricardo Defense
19th Dec 202411:49 amRNSHolding(s) in Company
18th Dec 202410:48 amRNSDirector/PDMR Shareholding
17th Dec 20243:40 pmRNSDirector/PDMR Shareholding
17th Dec 20243:39 pmRNSHolding(s) in Company
16th Dec 20247:01 amRNSRicardo to acquire E3 Advisory
16th Dec 20247:00 amRNSRicardo divests Ricardo Defense
11th Dec 20242:13 pmRNSHolding(s) in Company
2nd Dec 20245:01 pmRNSHolding(s) in Company
2nd Dec 202411:41 amRNSDirector/PDMR Shareholding
22nd Nov 20241:01 pmRNSDirector/PDMR Shareholding
22nd Nov 202412:51 pmRNSHolding(s) in Company
18th Nov 20243:31 pmRNSDirector/PDMR Shareholding
18th Nov 20242:02 pmRNSHolding(s) in Company - replacement
18th Nov 202412:46 pmRNSDirector/PDMR Shareholding
15th Nov 20244:20 pmRNSResult of AGM
30th Oct 202410:28 amRNSDirector/PDMR Shareholding
28th Oct 20245:29 pmRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSStrategy Update
17th Oct 20248:54 amRNSDirectorate Change
14th Oct 20242:12 pmRNSDirector/PDMR Shareholding
8th Oct 20245:39 pmRNSDirector/PDMR Shareholding
30th Sep 202411:15 amRNSTransaction in Own Shares
17th Sep 202411:04 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSPreliminary Results
3rd Sep 20247:00 amRNSNotice of Results and Investor Presentation
28th Aug 202412:00 pmRNSDirectorate Change
21st Aug 202410:52 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTrading Update
15th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 202410:50 amRNSDirectorate Change
12th Jun 20249:30 amRNSDirector/PDMR Shareholding
15th May 20243:20 pmRNSDirector/PDMR Shareholding
13th May 20249:25 amRNSDirector/PDMR Shareholding
3rd May 20247:43 amRNSDirectorate Change
30th Apr 20243:40 pmRNSDirector/PDMR Shareholding
22nd Apr 202411:14 amRNSDirector/PDMR Shareholding
22nd Apr 202411:08 amRNSHolding(s) in Company
11th Apr 20242:51 pmRNSDirector/PDMR Shareholding
3rd Apr 20241:48 pmRNSHolding(s) in Company
15th Mar 20245:30 pmRNSHolding(s) in Company
12th Mar 20245:30 pmRNSDirector/PDMR Shareholding
8th Mar 202410:30 amRNSInvestor Meet Company Webinar
7th Mar 20243:26 pmRNSDirector/PDMR Shareholding
7th Mar 202411:55 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSInterim Results
5th Mar 202410:04 amRNSDirectorate Change
13th Feb 20249:39 amRNSDirector/PDMR Shareholding
6th Feb 202410:14 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.